Clinical Trial Update: 0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 0.25% bupivacaine alone to a mixture with liposomal bupivacaine in patients undergoing total knee arthroplasty; the study is terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia

Drugs mentioned

• 0.25% bupivacaine (bupivacaine)
• liposomal bupivacaine (1.3%) (liposomal bupivacaine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Anesthesia | Phase 3 | Status: TERMINATED | Results posted: 2020-03-20